Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared on X/Twitter:
“Enjoyed reading this analysis of HMA-VEN and IC in patients ≥60 years old with newly-diagnosed IDHm AML led by Shai Shimony, Maximilian Stahl, Rory M. Shallis et al.
-151 pt (81 IC 70 HMA-VEN)
-cCR rate 67% for both groups
-2y OS 45% for cohort (51% for IC, 35% for HMA-VEN p=0.14).”
Source: Anand Patel/X